February 25, 2016: FemPulse Featured in MedTech Insight
FemPulse was featured in the February edition of MedTech Insights in an article titled “Neuromodulation Devices Stimulate Opportunities in Urology”. The article provided a comprehensive assessment of future innovation in the rapidly growing fields of neuromodulation for Overactive Bladder (OAB). While currently marketed devices provide effective therapy, they can be costly, invasive and require a […]
February 2, 2016: Third FemPulse Patent Granted
The US Patent Office has granted the third FemPulse patent (#9,248,285). This broad patent grants claims regarding stimulation of nerves adjacent the vaginal canal to stimulate the autonomic plexuses, as well as claims regarding controllers and sensors.
February 1, 2016: Don Deyo Named FemPulse CEO
Don Deyo joined FemPulse in the newly created role of Chief Executive Officer. Don is a 29-year veteran of Medtronic, PLC, where he served in a variety of executive leadership roles. He is founder and CEO of the consultancy firm, MedTech Execs and was CEO of Medallion Therapeutics, Inc. prior to joining FemPulse. Don brings […]
